Mpex Pharmaceuticals' Series D Round

Mpex Pharmaceuticals raised a round of funding on February 12, 2009.

Mpex Pharmaceuticals is a biopharmaceutical company developing an inhaled antibiotic for the treatment of cystic fibrosis and chronic obstructive pulmonary disease and therapies to combat the growing…

Articles about Mpex Pharmaceuticals' Series D Round: